Samus Therapeutics, Inc., a privately held, biopharmaceutical company developing small molecule epichaperome inhibitors , today announced the presentation of safety and pharmacokinetic data from...

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases,...

The IEC 61850 Global 2020 will take place as scheduled on 26-30 October 2020, on the Swapcard virtual event platform. In recognition of the importance of information sharing to keep up the...

Global Industrial Intelligence Awards – Zhanlu Award ceremony kicked off the World Artificial Intelligence Conference 2020 on July 10. Foxconn Industrial Internet cloud platform (Fii Cloud) was...

Alzheimer's disease has been an unsolved puzzle for scientists since the first patient was found over 100 years ago. Different theories like cholinergic hypothesis, amyloid cascade hypothesis, and...

The Biologic Association has enrolled over 6,000 active clinical members within the first six months of the site launch (www.thebiologicassociation.com). The Biologic Association (BA) is an...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced...

AFWERX FUSION, the U.S. Air Force's innovation arm and catalyst for fostering innovation within the Air Force, announces the final line-up of dynamic keynote speakers, panels and fireside chats...

Nouveau Monde (TSXV: NOU ; OTCQX: NMGRF ; Frankfurt: NM9), based in Quebec, Canada, focused on natural graphite flake and battery anode material, today announced that Christina Lalli, Director,...

A new study on Lilly's blood test for Alzheimer's disease (AD), P-tau217 (phosphorylated tau at threonine-217), was published today in JAMA. The results showed that P-tau217 distinguished AD from...